Erratum: Solution structural dynamics of HIV-1 reverse transcriptase heterodimer (Biochemistry (2009) 48 (7646) DOI: 10.1021/bi900790x);Solution structural dynamics of HIV-1 reverse transcriptase heterodimer

Biochemistry

Volumn 48, Issue 32, 2009, Pages 7646-7655

  Seckler, James M ^a   Howard, Kathryn J ^b   Barkley, Mary D ^a,b   Wintrode, Patrick L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; HYDROGEN; MASS SPECTROMETRY; STRUCTURAL DYNAMICS;

CATALYTIC SITES; CONFORMATIONAL CHANGE; CONSERVED RESIDUES; HETERO DIMERS; HIV-1 REVERSE TRANSCRIPTASE; HYDROGEN EXCHANGE; N-TERMINAL SEQUENCES; SEQUENCE INFORMATIONS;

CRYSTAL STRUCTURE;

DNA DIRECTED DNA POLYMERASE ALPHA; HETERODIMER; HYDROGEN; PROTEIN P66; PROTEIN SUBUNIT; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE;

AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; SIMULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 68849132703     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi1014024     Document Type: Erratum

References (42)

1. Coffin, J. M., Hughes, S. H., and Varmus, H. E. (1997) Retroviruses, Cold Spring Harbor Laboratory Press, Plainview, NY.
2. Wang, J., Smerdon, S. J., Jäger, J., Kohlstaedt, L. A., Rice, P. A., Friedman, J. M., and Steitz, T. A. (1994) Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. U.S.A. 91, 7242-7246.
3. Le Grice, S. F. J., Naas, T., Wohlgensinger, B., and Schatz, O. (1991) Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J. 10, 3905-3911.
4. Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Jr., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., Hizi, A., Hughes, S. H., and Arnold, E. (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. U.S.A. 90, 6320-6324.
5. Hsiou, Y., Ding, J., Das, K., Clark, A. D., Jr., Hughes, S. H., and Arnold, E. (1996) Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure 4, 853-860.
6. Rodgers, D. W., Gamblin, S. J., Harris, B. A., Ray, S., Culp, J. S., Hellmig, B., Woolf, D. J., Debouck, C., and Harrison, S. C. (1995) The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 92, 1222-1226.
7. Bahar, I., Erman, B., Jernigan, R. L., Atilgan, A. R., and Covell, D. G. (1999) Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function. J. Mol. Biol. 285, 1023-1037.
8. Madrid, M., Jacobo-Molina, A., Ding, J., and Arnold, E. (1999) Major subdomain rearrangement in HIV-1 reverse transcriptase simulated by molecular dynamics. Proteins 35, 332-337.
9. Madrid, M., Lukin, J. A., Madura, J. D., Ding, J., and Arnold, E. (2001) Molecular dynamics of HIV-1 reverse transcriptase indicates increased flexibility upon DNA binding. Proteins 45, 176-182.
10. Shen, L., Shen, J., Luo, X., Cheng, F., Xu, Y., Chen, K., Arnold, E., Ding, J., and Jiang, H. (2003) Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT. Biophys. J. 84, 3547-3563.
11. Carvalho, A. T. P., Fernandes, P. A., and Ramos, M. J. (2007) The excision mechanism in reverse transcriptase: pyrophosphate leaving and fingers opening are uncoupled events with the analogues AZT and d4T. J. Phys. Chem. B 111, 12032-12039.
12. Rodriguez-Barrios, F., Perez, C., Lobaton, E., Velazquez, S., Chamorro, C., San-Felix, A., Perez-Perez, M. J., Camarasa, M. J., Pelemans, H., Balzarini, J., and Gago, F. (2001) Identification of a putative binding site for [2′,5′-bis-O-(tert-butyldimethylsilyl)-β-D- ribofuranosyl]-3′-spiro-5″-(4″-amino-1″, 2″-oxathiole-2″,2″-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase. J. Med. Chem. 44, 1853-1865.
13. Rodríguez-Barrios, F., Balzarini, J., and Gago, F. (2005) The molecular basis of resilience to the effect of the Lys103Asn mutation in nonnucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations. J. Am. Chem. Soc. 127, 7570-7578.
14. Zhou, Z., Madrid, M., Evanseck, J. D., and Madura, J. D. (2005) Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase. J. Am. Chem. Soc. 127, 17253-17260.
15. Kensch, O., Restle, T., Wohrl, B. M., Goody, R. S., and Steinhoff, H. J. (2000) Temperature-dependent equilibrium between the open and closed conformation of the p66 subunit of HIV-1 reverse transcriptase revealed by site-directed spin labelling. J. Mol. Biol. 301, 1029-1039.
16. 15N relaxation measurements. Biochemistry 31, 9150-9157.
17. Pari, K., Mueller, G. A., DeRose, E. F., Kirby, T. W., and London, R. E. (2003) Solution structure of the RNase H domain of the HIV-1 reverse transcriptase in the presence of magnesium. Biochemistry 42, 639-650.
18. Mueller, G. A., Pari, K., DeRose, E. F., Kirby, T. W., and London,R. E. (2004) Backbone dynamics of the RNase H domain of HIV-1 reverse transcriptase. Biochemistry 43, 9332-9342.
19. Wales, T. E., and Engen, J. R. (2006) Hydrogen exchange mass spectrometry for the analysis of protein dynamics. Mass Spectrom. Rev. 25, 158-170.
20. Le Grice, S. F. J., Cameron, C. E., and Benkovic, S. J. (1995) Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol. 262, 130-144.
21. Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., and Barkley, M. D. (2006) Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase. Biochemistry 45, 2779-2789.
22. Tsutsui, Y., Liu, L., Gershenson, A., and Wintrode, P. L. (2006) The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry. Biochemistry 45, 6561-6569.
23. Divita, G., Rittinger, K., Restle, T., Immendorfer, U., and Goody, R. S. (1995) Conformational stability of dimeric HIV-1 and HIV-2 reverse transcriptases. Biochemistry 34, 16337-16346.
24. Zhang, Z., and Smith, D. L. (1993) Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 2, 522-531.
25. Huang, H., Chopra, R., Verdine, G. L., and Harrison, S. C. (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669-1675.
26. Sarafianos, S. G., Das, K., Tantillo, C., Clark, A. D., Jr., Ding, J., Whitcomb, J. M., Boyer, P. L., Hughes, S. H., and Arnold, E. (2001) Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20, 1449-1461.
27. Das, K., Lewi, P. J., Hughes, S. H., and Arnold, E. (2005) Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of nonnucleoside HIV-1 reverse transcriptase inhibitors. Prog. Biophys. Mol. Biol. 88, 209-231.
28. Englander, S. W., and Kallenbach, N. R. (1983) Hydrogen exchange and structural dynamics of proteins and nucleic acids. Q. Rev. Biophys. 16, 521-655.
29. Jacques, P. S., Wohrl, B. M., Howard, K. J., and Le Grice, S. F. J. (1994) Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers. J. Biol. Chem. 269, 1388-1393.
30. Hooft, R. W., Sander, C., and Vriend, G. (1996) Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins 26, 363-376.
31. Deng, Y., and Smith, D. L. (1999) Rate and equilibrium constants for protein unfolding and refolding determined by hydrogen exchangemass spectrometry. Anal. Biochem. 276, 150-160.
32. Engen, J. R., Smithgall, T. E., Gmeiner, W. H., and Smith, D. L. (1997) Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry. Biochemistry 36, 14384-14391.
33. Weis, D. D., Wales, T. E., Engen, J. R., Hotchko, M., and Ten Eyck, L. F. (2006) Identification and characterization of EX1 kinetics in H/D exchange mass spectrometry by peak width analysis. J. Am. Soc. Mass Spectrom. 17, 1498-1509.
34. Abbondanzieri, E. A., Bokinsky, G., Rausch, J. W., Zhang, J. X., Le Grice, S. F. J., and Zhuang, X. (2008) Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453, 184-189.
35. Davies, J. F., II, Hostomska, Z., Hostomsky, Z., Jordan, S. R., and Matthews, D. A. (1991) Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 252, 88-95.
36. Bahar, I. (2009) Anisotropic Network Model web server, http://ignmtest.ccbb.pitt.edu/cgi-bin/anm/anm1.cgi.
37. Jaeger, J., Restle, T., and Steitz, T. A. (1998) The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. EMBO J. 17, 4535-4542.
38. Sarafianos, S. G., Das, K., Clark, A. D., Jr., Ding, J., Boyer, P. L., Hughes, S. H., and Arnold, E. (1999) Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids. Proc. Natl. Acad. Sci. U.S.A. 96, 10027-10032.
39. Sarafianos, S. G., Clark, A. D., Jr., Das, K., Tuske, S., Birktoft, J. J., Ilankumaran, P., Ramesha, A. R., Sayer, J. M., Jerina, D. M., Boyer, P. L., Hughes, S. H., and Arnold, E. (2002) Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J. 21, 6614-6624.
40. Peletskaya, E. N., Kogon, A. A., Tuske, S., Arnold, E., and Hughes, S. H. (2004) Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA. J. Virol. 78, 3387-3397.
41. Tuske, S., Sarafianos, S. G., Clark, A. D., Jr., Ding, J., Naeger, L. K., White, K. L., Miller, M. D., Gibbs, C. S., Boyer, P. L., Clark, P., Wang, G., Gaffney, B. L., Jones, R. A., Jerina, D. M., Hughes, S. H., and Arnold, E. (2004) Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat. Struct. Mol. Biol. 11, 469-474.
42. Ceccherini-Silberstein, F., Gago, F., Santoro, M., Gori, C., Svicher, V., Rodriguez-Barrios, F., d'Arrigo, R., Ciccozzi, M., Bertoli, A., d'Arminio Monforte, A., Balzarini, J., Antinori, A., and Perno, C. F. (2005) High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations. J. Virol. 79, 10718-10729.